Neogen Corporation Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Neogen Corporation (NEOG) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 1.00 million shares as of 2025-05-31, per its 10-K filed 2025-07-30.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2025-07-30
- 2025-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.00M shares.
- 2024-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 961.00K shares.
- 2023-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 766.00K shares.
- 2022-11-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 789.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2025-05-31 | 1.00M shares 10-K · filed 2025-07-30 |
| 2024-05-31 | 961.00K shares 10-K · filed 2025-07-30 |
| 2023-05-31 | 766.00K shares 10-K · filed 2025-07-30 |
| 2022-11-30 | 789.00K shares 10-Q · filed 2023-01-09 |
| 2022-08-31 | 253.00K shares 10-Q · filed 2022-09-30 |
| 2022-05-31 | 257.00K shares 10-K · filed 2024-07-30 |
| 2022-02-28 | 212.00K shares 10-Q · filed 2022-04-01 |
| 2021-11-30 | 213.00K shares 10-Q · filed 2021-12-30 |
| 2021-05-31 | 121.00K shares 10-K · filed 2023-08-15 |
| 2020-05-31 | 0.00 shares 10-K · filed 2022-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |